US Dollar vs Yen

登録してリアルタイムのアラート、カスタムポートフォリオ、市場の動きを入手してください。

ホーム
投資
株式
ヨーロッパ
EU
Weaccess Group (MLWEA) 銘柄情報

Weaccess Group (MLWEA)

2.80

0.00

(0.00%)

終了 6月14日 12:30AM

Weaccess Group (MLWEA) 銘柄情報

リアルタイムのディスカッションと取引のアイデア: 当社の強力なプラットフォームで自信を持って取引できます。

プレミアム

通貨

2.80

( - )

買値

2.80

売値

2.80

出来高

0.00

0.00 日の範囲 0.00

0.65 52 週間の範囲 2.80

時価総額

前日終値

2.80

始値

-

時刻

最終取引時間

財務取引量

-

VWAP

-

平均取引量 (3 か月)

460 €

発行済株式数

1,107,276

配当利回り

PER

-167.71

1 株当たり利益 (EPS)

-0.02

歳入

1.31M

純利益

-25.3k

Weaccess Group, Société Anonyme operates as an internet service provider in France. It offers internet access, business telephony, private networks, unified communications, cybersecurity, distributors, and walkie-talkie applications. The company was incorporated in 1995 and is headquartered in Saint... Weaccess Group, Société Anonyme operates as an internet service provider in France. It offers internet access, business telephony, private networks, unified communications, cybersecurity, distributors, and walkie-talkie applications. The company was incorporated in 1995 and is headquartered in Saint-Étienne-du-Rouvray, France. 詳細を表示

セクター

Media

業界

Telecommunications

ウェブサイト

www.weaccess.fr

本社

Saint-Étienne-du-rouvray, France

設立

1995

Weaccess Group is listed in the Media sector of the ユーロネクスト with ticker MLWEA. The last closing price for Weaccess was 2.80 €. Over the last year, Weaccess shares have traded in a share price range of 0.65 € to 2.80 €.

Weaccess currently has 1,107,276 shares in issue. The market capitalisation of Weaccess is 3.10 € million. Weaccess has a price to earnings ratio (PE ratio) of -167.71.

表示するニュースはありません。

期間 †	前日比	前日比 %	始値	高値	安値	平均出来高	VWAP
1	0	0	2.8	2.8	2.8	0	0	DE
4	0	0	2.8	2.8	2.8	14	2.8	DE
12	0.06	2.1897810219	2.74	2.8	2.24	89	2.58732013	DE
26	0.6	27.2727272727	2.2	2.8	1.53	245	2.17432593	DE
52	2.15	330.769230769	0.65	2.8	0.65	419	1.67264343	DE
156	0.4	16.6666666667	2.4	2.8	0.38	271	1.11177393	DE
260	0.2	7.69230769231	2.6	2.8	0.38	194	1.33995792	DE

MLWEA - Frequently Asked Questions (FAQ)

What is the current Weaccess Group share price?

The current share price of Weaccess Group is 2.80 €

How many Weaccess Group shares are in issue?

Weaccess Group has 1,107,276 shares in issue

What is the market cap of Weaccess Group?

The market capitalisation of Weaccess Group is EUR 3.1M

What is the 1 year trading range for Weaccess Group share price?

Weaccess Group has traded in the range of 0.65 € to 2.80 € during the past year

What is the PE ratio of Weaccess Group?

The price to earnings ratio of Weaccess Group is -167.71

What is the cash to sales ratio of Weaccess Group?

The cash to sales ratio of Weaccess Group is 2.37

What is the registered address of Weaccess Group?

The registered address for Weaccess Group is 59 rue Caroline Herschel, Saint-Étienne-du-Rouvray, Haute-Normandie, 76800

What is the Weaccess Group website address?

The website address for Weaccess Group is www.weaccess.fr

Which industry sector does Weaccess Group operate in?

Weaccess Group operates in the Telecommunications sector

fricassee

fricassee 6分前

Researchfyi, glad to see you're still with us, and you haven't kicked the Liquidmetal bucket.

gutek

"Dump and dilute schemes involve companies that repeatedly issue shares for no reason other than taking investors' money. Companies using this kind of scheme tend to reverse split the stock periodically. A reverse split is where the corporation consolidates stocks (more shares become less) to give t

MasterBlastr

MasterBlastr 8分前

Clark is becoming a great clutch player under pressure. I like his chances.

Soog

We've exploded on every board

Eli's Gone

Eli's Gone 15分前

amazing what he did facing single and sometimes double coverage for 94 feet every trip up the court every nite...

gimmee greenbacks

gimmee greenbacks 16分前

Yeah…I know..my bad lol

BIEL

hankmanhub

hankmanhub 19分前

SIMPLY PUT, WHAT WILL NWBO HAVE TO PAY the FDA to get dcvac-l approved for GBM?
From AI:

Northwest Biotherapeutics (NWBO) will likely have to pay $0 (zero dollars) to the FDA to get DCVax-L approved for Glioblastoma Multiforme (GBM) due to federal exemption programs.

Lazy Oaks

Lazy Oaks 25分前

hankmanhub

hankmanhub 32分前

From AI:
There are no direct FDA application fees or user fees charged to sponsors for filing an Investigational New Drug (IND) application. The FDA does not charge for submitting the application itself, nor for the pre-IND interactions.While the IND application itself is free, the process of

SSKILLZ1

SSKILLZ1 34分前

I'm absolutely at a loss for words. This is amazing. And Brunson was brilliant in game 5.

lakers17

lakers17 35分前

Congrats on the championship. San Antonio had double digit leads every game. Brunson is a stud.

Mozy429

Mozy429 35分前

If you just look at his history of posting, you’ll see exactly why he’s here. He’s literally posted a few months ago that he craps on the company because he wants cheaper shares. It’s there.Trust me, him, Henry, csuck, rack, Jim, I and the rest of the village idiots are not short. They are buying an

glenngroove

glenngroove 37分前

I'll call them on Monday

Thompson123

Thompson123 42分前

SPCX $130 Next week?

nyt

The only thing coming is more of the same that you've been dished for 27 years more of the same Sorry Charlie is what it is...

because..... That's what vplm is all about. End of story

Eli's Gone

Eli's Gone 46分前

Congrats SSKillz1.....you deserve this...enjoy

sam1933

sam1933 52分前

⬆️ Canary Capital $HBAR's supply... 662,973,063.02

Soog

Soog 1時間前

#1 on the breakout board

sam1933

sam1933 1時間前

BIG!!! By combining the strengths of AI, distributed ledger technology and post-quantum security expertise, QAIT, SEALCOIN, Hedera and The Hashgraph Group aim to establish a new benchmark for quantum readiness assessment and digital resilience in the age of quantum computing.

bidmark

bidmark 1時間前

How much does it cost (in shares) to file and process an application with the FDA?

MasterBlastr

MasterBlastr 1時間前

He's been feelin' it.

OMOLIVES

OMOLIVES 1時間前

She took you to the right place in NC...no doubt. And kudos for saying FL doesn't count. It surely doesn't..lol.

HyGro

HyGro 1時間前

Evidence is clear - NWBO DIDN'T FILE WITH THE FDA. No biotech in their right mind would pass up filing for U.S. approval unless they knew they would fail.
You can wait as long as you want, FDA isn't going to accept the P3 trial for an review.

Tactical Income Portfoli...

Bmo Sia Focused North Am...

Agf Global Strategic Inc...

Mkango Resources

Cbonds 2.05% until 11sep...

Megmilk Snow Brand (PK)

Gores Holdings IX

Pioneer Natural Resources

Northwest Biotherapeutics

Malaysia Airports Holdin... ()

Lyx Robots & Ai

Westpac Banking

Delayed Upgrade Clock

顧客サポート: +44 (0) 203 8794 460 | support@advfn.com

ADVFNのサービスをご利用いただくには、利用規約

ADVFN

すでにアカウントをお持ちですか？サインイン

アカウントをお持ちでないですか？登録

登録することで、ADVFN の利用規約を読み、理解し、同意したこと、および私が個人投資家であることを確認します。